Sodium Valproate, a Histone Deacetylase Inhibitor, Is Associated With Reduced Stroke Risk After Previous Ischemic Stroke or Transient Ischemic Attack

Brookes, RL; Crichton, S; Wolfe, CDA; Yi, Q; Li, L; Hankey, GJ; Rothwell, PM; Brookes, RL; Crichton, S; Wolfe, CDA; Yi, Q; Li, L; Hankey, GJ; Rothwell, PM; Markus, HS; - view fewer (2018) Sodium Valproate, a Histone Deacetylase Inhibitor, Is Associated With Reduced Stroke Risk After Previous Ischemic Stroke or Transient Ischemic Attack. Stroke , 49 (1) pp. 54-61. 10.1161/STROKEAHA.117.016674 . Green open access

https://ift.tt/2k0R79Z